A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD

NCT06731959 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: Flexlamose
DRUG: Placebo

Sponsor

Aer Therapeutics